Gene · 5696
Papers2,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CANDLE syndrome: A rare case report documented for the first time in the Middle East. | Medicine (Baltimore) | 2025 | 40660608 | PubTator, text mining | PubMed |
| Association of gut microbiota and immune gene expression with response to targeted therapy in BRAF mutated melanoma. | Sci Rep | 2025 | 40659866 | PubTator, text mining | PubMed |
| The value of plasma immunoproteasome for predicting coronary collateral circulation in ST-elevation myocardial infarction. | Biomark Med | 2025 | 40536446 | PubTator, text mining | PubMed |
| scFocus: Detecting branching probabilities in single-cell data with SAC. | Comput Struct Biotechnol J | 2025 | 40520594 | PubTator, text mining | PubMed |
| LMP7-Specific Inhibitor M3258 Modulates the Tumor Microenvironment of Triple-Negative Breast Cancer and Inflammatory Breast Cancer. | Cancers (Basel) | 2025 | 40507366 | PubTator, text mining | PubMed |
| Gene expression inference based on graph neural networks using L1000 data. | Brief Bioinform | 2025 | 40505083 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| Updates in the Management of Hereditary Periodic Fever Syndromes in Children. | Cureus | 2025 | 40376361 | PubTator, text mining | PubMed |
| Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy. | Biomed Pharmacother | 2025 | 40347847 | PubTator, text mining | PubMed |
| MRI-based machine learning reveals proteasome subunit PSMB8-mediated malignant glioma phenotypes through activating TGFBR1/2-SMAD2/3 axis. | Mol Biomed | 2025 | 40335825 | PubTator, text mining | PubMed |
| Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma. | PLoS One | 2025 | 40334200 | PubTator, text mining | PubMed |
| Integrated Analysis of PSMB8 Expression and Its Potential Roles in Hepatocellular Carcinoma. | Dig Dis Sci | 2025 | 40261568 | PubTator, text mining | PubMed |
| Editorial for the Special Issue "Cutaneous Biology, Molecular Dermatology and Dermatopathology". | Int J Mol Sci | 2025 | 40141335 | PubTator, text mining | PubMed |
| Applying integrated transcriptome and single-cell sequencing analysis to develop a prognostic signature based on M2-like tumor-associated macrophages for breast cancer. | Discov Oncol | 2025 | 40131644 | PubTator, text mining | PubMed |
| Lentinan alleviates angiotensin II-induced myocardial remodeling through LMP7-SOCS3 signaling. | Int J Biol Macromol | 2025 | 40101827 | PubTator, text mining | PubMed |
| Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer. | J Transl Med | 2025 | 40012053 | PubTator, text mining | PubMed |
| Correction: Psmb8 inhibits mitochondrial fission and alleviates myocardial ischaemia/reperfusion injury by targeting Drp1 degradation. | Cell Death Dis | 2025 | 39952946 | PubTator, text mining | PubMed |
| Molecular dynamics simulation of wild and mutant proteasome subunit beta type 8 (PSMB8) protein: Implications for restoration of inflammation in experimental autoimmune encephalomyelitis pathogenesis. | Heliyon | 2025 | 39802026 | PubTator, text mining | PubMed |
| Genetic Commonalities Between Metabolic Syndrome and Rheumatic Diseases Through Disease Interactome Modules. | J Cell Mol Med | 2025 | 39789419 | PubTator, text mining | PubMed |
| Downregulation of the immunoproteasome subunit PSMB8 attenuates sepsis-associated acute kidney injury through the NF-κB pathway. | Immunobiology | 2025 | 39733737 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5696/papers?page=4